Nano-X Imaging Ltd. (NASDAQ:NNOX) Receives Average Rating of “Moderate Buy” from Brokerages

Nano-X Imaging Ltd. (NASDAQ:NNOX) has been given a consensus rating of “Moderate Buy” by the six analysts that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, one has issued a buy rating and three have issued a strong buy rating on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $5.00.

Several equities research analysts have issued reports on NNOX shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Nano-X Imaging in a report on Friday, April 10th. Zacks Research downgraded Nano-X Imaging from a “hold” rating to a “strong sell” rating in a report on Wednesday, April 22nd. D. Boral Capital reissued a “buy” rating and issued a $5.00 target price on shares of Nano-X Imaging in a research report on Monday, April 20th. Finally, Cantor Fitzgerald upgraded shares of Nano-X Imaging to a “strong-buy” rating in a research note on Wednesday, March 4th.

Nano-X Imaging Price Performance

Shares of Nano-X Imaging stock opened at $1.70 on Tuesday. The business has a fifty day simple moving average of $2.21 and a two-hundred day simple moving average of $2.76. Nano-X Imaging has a 1 year low of $1.59 and a 1 year high of $5.72. The company has a market capitalization of $118.30 million, a price-to-earnings ratio of -1.07 and a beta of 1.19.

Nano-X Imaging (NASDAQ:NNOX) last announced its quarterly earnings results on Monday, April 20th. The company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.35). Nano-X Imaging had a negative net margin of 790.87% and a negative return on equity of 64.65%. The business had revenue of $3.72 million for the quarter, compared to analyst estimates of $3.99 million. During the same period in the prior year, the business earned ($0.21) EPS. As a group, equities analysts anticipate that Nano-X Imaging will post -0.65 earnings per share for the current fiscal year.

Institutional Trading of Nano-X Imaging

A number of institutional investors have recently bought and sold shares of NNOX. Kestra Advisory Services LLC bought a new position in shares of Nano-X Imaging during the first quarter worth approximately $26,000. Independent Financial Group LLC bought a new stake in shares of Nano-X Imaging in the first quarter valued at approximately $26,000. Interchange Capital Partners LLC acquired a new stake in Nano-X Imaging during the fourth quarter worth approximately $28,000. Aristides Capital LLC bought a new position in Nano-X Imaging during the 4th quarter worth $30,000. Finally, Hsbc Holdings PLC bought a new position in Nano-X Imaging during the 1st quarter worth $35,000. Institutional investors own 21.49% of the company’s stock.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.